Mounjaro Side Effects: What to Expect & How to Manage Them
Reviewed by Dr Abdishakur M Ali, GP & Clinical Director: Side effects are among the most common reasons people stop weight loss medication prematurely — often unnecessarily. Most Mounjaro side effects are temporary, manageable, and significantly improve once the body adjusts. This guide gives you the honest picture.
Side Effects Overview
Mounjaro (tirzepatide) is generally well tolerated by the majority of people who take it. Its side effect profile is dominated by gastrointestinal effects — a consequence of its mechanism of action, which slows gastric emptying and alters gut hormone signalling. These effects are most pronounced during dose escalation and typically diminish significantly at the maintenance dose.
In the SURMOUNT-1 clinical trial, the proportion of participants discontinuing due to side effects was approximately 4.3% at the 15mg dose — meaning over 95% of participants on the maximum dose continued treatment. Side effects were the primary reason for discontinuation, but most participants who experienced them chose to continue despite them.
Common Side Effects
Gastrointestinal Effects (Very Common — ≥1 in 10 people)
Nausea
The most commonly reported side effect — particularly during dose escalation. Usually mild to moderate. Tends to improve significantly by weeks 6–10 and often resolves at maintenance dose.
Diarrhoea
Common during initiation and dose increases. Usually transient. Staying well hydrated is important. Typically improves within 2–4 weeks of any dose increase.
Constipation
Paradoxically, some users experience constipation rather than diarrhoea — both can occur at different stages. Adequate fibre and fluid intake helps significantly.
Vomiting
Less common than nausea but related. Usually triggered by eating too quickly, eating large portions, or consuming high-fat foods. Adjusting eating behaviour typically resolves it.
Indigestion / Reflux
Slowed gastric emptying can cause indigestion or acid reflux, particularly when eating large meals or lying down after eating. Smaller, more frequent meals help.
Fatigue
Some users report tiredness, particularly in the early weeks. Often related to reduced calorie intake rather than the medication directly. Usually temporary.
Other Common Effects
- Decreased appetite — the intended effect of Mounjaro, also classified as a “side effect” in trial data. Very common and expected.
- Headache — common, typically mild. Often associated with reduced fluid or calorie intake. Ensure adequate hydration.
- Dizziness — occasional, particularly during the first few weeks. Can be related to reduced calorie intake or mild dehydration.
- Injection site reactions — redness, swelling, or itching at the injection site. Usually mild and short-lived. Rotating injection sites reduces frequency.
Practical Tips for Managing Gastrointestinal Side Effects
- Eat smaller portions — your stomach empties more slowly on Mounjaro; large meals are more likely to cause nausea and discomfort
- Eat slowly and chew thoroughly — rushing meals exacerbates nausea significantly
- Avoid high-fat, fried, or very sweet foods — these are the most common dietary triggers for Mounjaro-associated nausea
- Stay well hydrated — dehydration worsens nausea and diarrhoea; aim for 1.5–2 litres of fluid daily
- Eat bland, low-fat foods during the worst nausea periods — plain rice, toast, crackers, bananas
- Do not lie down immediately after eating — wait at least 30 minutes after meals
- Inject at a consistent time weekly — irregular timing can affect tolerance
- Ask your prescriber about slowing escalation — if side effects at a new dose are difficult, staying at the lower dose for an extra 4 weeks is a valid option
Slow the escalation if needed: The standard 4-week escalation schedule is a guideline, not a rule. If nausea at a new dose is significant, it is clinically appropriate to remain at the lower dose for a further 4 weeks before increasing. Speak to your prescriber — they can adjust your titration plan accordingly.
How Long Do Mounjaro Side Effects Last?
| Phase | Typical side effect experience |
|---|---|
| Weeks 1–4 (2.5mg) | Mild to moderate nausea most likely. Body beginning to adjust to GIP/GLP-1 signalling. Appetite reduction begins. |
| Weeks 5–8 (5mg) | Another adjustment period with dose increase. GI effects may recur briefly. Most users find this phase easier than initiation. |
| Weeks 9–16 (7.5–10mg) | Progressive dose increases; some GI effect with each step. Body increasingly adapted. Side effects shorter-lived than initial phase. |
| Week 21+ (15mg maintenance) | Most users reach a settled state. GI side effects much reduced or absent. Ongoing appetite suppression without the early discomfort. |
The key message: side effects are front-loaded into the dose escalation phase. Persistence through this period — with good symptom management — is rewarded with significantly better tolerability at maintenance dose alongside substantially greater weight loss.
Uncommon & Serious Side Effects
Pancreatitis (Uncommon)
Inflammation of the pancreas is a rare but serious risk associated with GLP-1 and GIP receptor agonists. Symptoms include persistent, severe abdominal pain — often radiating to the back — along with nausea and vomiting that does not resolve. If you experience this, stop Mounjaro immediately and seek urgent medical attention.
Gallbladder Disease (Uncommon)
Rapid weight loss — regardless of method — is associated with an increased risk of gallstone formation. Mounjaro’s significant efficacy makes this worth noting. Symptoms include right upper abdominal pain, particularly after fatty meals, that may radiate to the shoulder. Report any such symptoms to your prescriber promptly.
Increased Heart Rate
A small but measurable increase in resting heart rate has been observed with tirzepatide in clinical trials. For most people this is clinically insignificant, but it should be discussed with your prescriber if you have pre-existing cardiac conditions.
Hypoglycaemia (in diabetes patients)
Mounjaro lowers blood sugar — if you are taking insulin or a sulphonylurea alongside it, hypoglycaemia risk increases. Your prescriber will likely recommend adjusting doses of these medications when starting Mounjaro. Monitor blood sugar carefully and know the symptoms of hypoglycaemia.
Red Flags — When to Seek Urgent Medical Attention
Stop Mounjaro and seek urgent medical attention if you experience:
- Severe, persistent abdominal pain — especially if radiating to your back (possible pancreatitis)
- Signs of a severe allergic reaction: swelling of the face, lips, tongue or throat; difficulty breathing; rapid heartbeat with rash
- Symptoms of very low blood sugar (if diabetic): trembling, sweating, confusion, loss of consciousness
- Significant changes in vision (possible diabetic retinopathy in diabetic patients)
- Persistent right upper abdominal pain (possible gallbladder disease)
Mounjaro and Hair Loss
Temporary hair thinning — known as telogen effluvium — has been reported by some Mounjaro users. This is not a direct pharmacological side effect of tirzepatide itself; it is a well-recognised physiological response to significant and rapid weight loss, which disrupts the normal hair growth cycle.
Telogen effluvium typically begins 2–3 months after a period of significant calorie restriction or rapid weight loss and usually resolves within 3–6 months as the body adjusts. Maintaining adequate protein intake (at least 1.2g per kg of body weight per day) during weight loss helps minimise hair thinning.
Who Should Not Take Mounjaro
- Pregnant women, or women planning pregnancy — Mounjaro must be stopped at least 2 months before attempting conception
- Women who are breastfeeding
- People with a personal or family history of medullary thyroid carcinoma
- People with multiple endocrine neoplasia type 2 (MEN2)
- People with a history of pancreatitis
- People currently taking another GLP-1 agonist, GIP agonist, or insulin without medical supervision
💉 Prescription Weight Loss
Mounjaro (Tirzepatide)
MHRA-approved once-weekly injection. Dual GIP & GLP-1 action — the most effective injectable weight loss treatment currently available in the UK.
View weight loss treatments →Concerned About Side Effects?
Our GPhC-registered pharmacist independent prescribers can advise on managing side effects, adjusting your dose schedule, or whether Mounjaro is the right treatment for you.
View Weight Loss Treatments →Medical disclaimer: This article is for informational purposes only and does not constitute medical advice. Mounjaro (tirzepatide) is a prescription-only medicine in the UK — always complete a full medical consultation before starting treatment. Always consult a qualified healthcare professional regarding your individual circumstances. In a medical emergency, call 999.
Frequently Asked Questions About Mounjaro Side Effects
What are the most common side effects of Mounjaro?
The most common side effects are gastrointestinal: nausea (very common), diarrhoea (very common), vomiting (common), and constipation (common). These are most frequent during dose escalation and significantly improve as the body adjusts over weeks 6–10 of each dose increase.
How long do Mounjaro side effects last?
Gastrointestinal side effects are most pronounced during the first 4–8 weeks and during each dose increase. For most people, nausea significantly reduces or resolves by weeks 6–10. Side effects at the 15mg maintenance dose are usually much milder than during escalation.
How can I reduce nausea from Mounjaro?
Eat smaller, more frequent meals; avoid high-fat, spicy, or very sweet foods; eat slowly; stay well hydrated; and avoid lying down immediately after eating. If nausea is severe, speak to your prescriber — dose escalation can be slowed to allow better adjustment.
Is Mounjaro safe long-term?
Mounjaro has an established safety profile from clinical trials covering up to 72 weeks of treatment and is MHRA approved for long-term use. Ongoing prescriber monitoring is recommended. The benefit-risk profile is strongly favourable for eligible adults with obesity or overweight with comorbidities.
What are the serious side effects of Mounjaro?
Serious but uncommon side effects include pancreatitis (severe abdominal pain radiating to the back — seek urgent medical attention), gallbladder disease, and increased heart rate. Rare but possible: severe allergic reactions. Stop treatment and seek immediate medical attention if any serious symptoms occur.
Can Mounjaro cause hair loss?
Some users experience temporary hair thinning (telogen effluvium) — this is typically caused by rapid weight loss rather than tirzepatide itself. It usually resolves within 3–6 months. Maintaining adequate protein intake during treatment (at least 1.2g/kg/day) helps minimise this effect.
References
- Jastreboff AM, et al. Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). NEJM. 2022;387:205–216. Available at: nejm.org
- Electronic Medicines Compendium. Mounjaro solution for injection — SmPC. Available at: medicines.org.uk/emc
- NICE. Tirzepatide for managing overweight and obesity (TA1026). Available at: nice.org.uk/guidance/ta1026
- NHS. Obesity — Treatment. Available at: nhs.uk/conditions/obesity/treatment
- Gallo M, et al. Hair loss and tirzepatide: understanding telogen effluvium in the context of GLP-1 receptor agonists. Clinical Endocrinology. 2024. Available at: pubmed.ncbi.nlm.nih.gov